Oncology R&D: emerging therapies and new challenges
Oncology research and development is a hotbed of activity. But with new therapeutic approaches come new challenges; what are these challenges, and how are leaders in the space responding?
In Association With ICON Biotech
Meet critical milestones
Overcoming the first hurdles: Navigating early phase challenges for biotechs
Transforming CML patient monitoring with ICON’s innovative RNA-based NGS assay
Cancer therapies for young adults: The need for tailored treatment and diversity
Diabesity: Overlapping pathophysiology informs multi-indication treatment
